Sponsored Content

An Upbeat Outlook Guides This Duchenne Family

This content is sponsored by Sarepta Therapeutics and is intended for US audiences only. Any other present or future content posted by the contributor, not expressly designated as “Sarepta Therapeutics-sponsored content” is not associated with Sarepta. Brandi’s son Beck is an actual patient who is taking AMONDYS 45 (casimersen).  The…

Meet Gaven, an Actual AGAMREE^® (vamorolone) Patient

Insights Into Living With Duchenne Muscular Dystrophy (DMD) Gaven lives in Texas, sharing a home with his mother, father, and 12-year-old brother, Tristan. Like many 10-year-old boys, he enjoys visits to the museum, going to restaurants, and most of all, riding motorcycles. His parents describe him as logical…

Catalyst Pathways^®: Your Path to a Better Tomorrow

Duchenne muscular dystrophy (DMD) is a rare genetic disorder that causes progressive muscle weakness. People living with DMD and their families face a variety of challenges every day. A path to prompt, affordable treatment should not be one of them. That is why Catalyst Pharmaceuticals created Catalyst Pathways®,…